Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling.
about
Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γIntegration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine.Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial.The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃Effects of Xylo-Oligosaccharides on Broiler Chicken Performance and Microbiota.Agave Inulin Supplementation Affects the Fecal Microbiota of Healthy Adults Participating in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infectionDietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.Intestinal PPARγ signalling is required for sympathetic nervous system activation in response to caloric restriction.The role of vitamin D in cancer prevention and treatment.The role of vitamin D in cancer prevention and treatment.Vitamin D in cancer chemoprevention.Cutting edge: Vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection.Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial.Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases.PPARγ in Inflammatory Bowel Disease.Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum".Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease.Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis.The dietary histone deacetylase inhibitor sulforaphane induces human beta-defensin-2 in intestinal epithelial cells.An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis.Inflammatory Bowel Disease and Immunonutrition: Novel Therapeutic Approaches Through Modulation of Diet and the Gut Microbiome.Eicosanoid modulation by the short-chain fatty acid n-butyrate in human monocytes.Effects of xylo-oligosaccharide and flavomycin on the immune function of broiler chickens.Vitamin B1 Helps to Limit Growth Regulating Innate Immunity in a Peroxisome Proliferator-Activated Receptor-γ-Dependent Manner
P2860
Q28235771-8B4D306D-5B26-4E80-A1B3-FE098A9992F8Q30538765-F0FC2180-F382-4DBF-89F4-999089F96702Q31159857-797930D5-5EB9-44BC-B81D-FD7B596BB340Q34033348-B1131CCC-E5F2-43F3-8CA3-F30C1214E4EFQ34265202-C963645B-D252-43A8-AB92-A3AA98C1C570Q35188826-CEB11930-C990-46E8-8EDC-939ADADCA958Q35669265-773C2D37-9DB8-4366-B702-89D0E4480E10Q35707540-1A49F7B4-6F13-419C-B042-D4D72809D626Q37033404-C3C282C2-99D7-4F58-A8C9-EB0725288FDDQ37137502-452BFAB3-81AD-441D-82CF-5DBDD8EE8CC5Q37148781-EBF260DF-AA35-4589-AF35-E0D9C91D92B1Q37419913-C2290C36-2653-4716-973D-C802F08A36A1Q37761548-6FA6268C-32FA-4589-BD27-F8508D3DEC5CQ38004753-98EEE7BD-5AE0-45BC-AD97-6F8126A8D131Q38412880-41F8AB21-F494-4F0E-AC9E-1976DBF68778Q38988109-BCFAF6A1-5CCE-409D-A094-3012356D5B96Q39065664-E48E5013-7C6F-452F-8C26-E9CD51E61D03Q39878010-EC1440EF-FD98-4024-B4B1-2B6F7AF99E2CQ41544554-A14BD992-6F0F-4749-8F40-61005B9B3D59Q42038488-3D00BB79-EA3B-42B4-8EA7-F6CAACCF5741Q42589189-009C73B9-ABBB-41BA-8E0F-790EB9ADADA9Q42709676-424DB515-A9C0-4B3D-9CF2-E7AB8775CC60Q44400760-E17DF999-E080-4535-9BC2-CDF6F537C2C5Q44822234-850E9973-B812-49CF-9BBE-9513DD165C33Q45796015-E91866B5-6ECA-4D89-81F7-3AED215D7D66Q51450186-27A38B44-A3C2-4C88-8903-FC00A3FF8E7AQ52564079-DAF7596C-7316-4823-B45F-F6B0469E061EQ54272518-44FDE24B-5B6F-48E6-B331-32EA528659E6Q55019014-4F094941-A3DF-485B-8556-EB129D4C8F9FQ58773569-800ACB87-888C-4F7E-A88A-15258E3E489C
P2860
Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Involvement of different nucle ...... ducible NF kappa B signalling.
@en
Involvement of different nucle ...... ducible NF kappa B signalling.
@nl
type
label
Involvement of different nucle ...... ducible NF kappa B signalling.
@en
Involvement of different nucle ...... ducible NF kappa B signalling.
@nl
prefLabel
Involvement of different nucle ...... ducible NF kappa B signalling.
@en
Involvement of different nucle ...... ducible NF kappa B signalling.
@nl
P2093
P50
P1433
P1476
Involvement of different nucle ...... ducible NF kappa B signalling.
@en
P2093
Markus Schwab
Oliver Schröder
Veerle Reynders
P304
P356
10.1016/J.MOLIMM.2007.04.010
P577
2007-05-22T00:00:00Z